Chemoinformaics analysis of 23-O-acetylshengmanol xyloside
| Molecular Weight | 662.861 | nRot | 7 |
| Heavy Atom Molecular Weight | 604.397 | nRig | 33 |
| Exact Molecular Weight | 662.403 | nRing | 7 |
| Solubility: LogS | -3.526 | nHRing | 2 |
| Solubility: LogP | 3.679 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 105 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 47 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 58 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 37 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 108.484 |
| nHD | 4 | BPOL | 66.866 |
| QED | 0.181 |
| Synth | 6.561 |
| Natural Product Likeliness | 2.956 |
| NR-PPAR-gamma | 0.95 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.85 |
| Pgp-sub | 0.601 |
| HIA | 0.043 |
| CACO-2 | -5.312 |
| MDCK | 0.0000343 |
| BBB | 0.028 |
| PPB | 0.873923 |
| VDSS | 0.749 |
| FU | 0.0876613 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.117 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.711 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.041 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.364 |
| CYP3a4-sub | 0.304 |
| CL | 1.177 |
| T12 | 0.164 |
| hERG | 0.259 |
| Ames | 0.249 |
| ROA | 0.84 |
| SkinSen | 0.082 |
| Carcinogencity | 0.04 |
| EI | 0.006 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.834 |
| Antiviral | Yes |
| Prediction | 0.788463 |